Drotrecogin alfa (activated) in patients with severe sepsis and a high risk of death
-
* Corresponding author: Jan O Friedrich j.friedrich@utoronto.ca
Critical Care 2006, 10:427 doi:10.1186/cc5117
See related letter by Williams et al., http://ccforum.com/content/10/5/424, related commentary by Friedrich et al., http://ccforum.com/content/10/3/145, related letter by Agarwal and Nath, http://ccforum.com/content/10/4/416, related reply by Friedrich et al., http://ccforum.com/content/10/4/420 and related letter by Saxena and Williams, http://ccforum.com/content/10/5/422
Accesses
- Last 30 days: 32 accesses
- Last 365 days: 230 accesses
- All time: 3111 accesses